Current:Home > MarketsThe FDA clears updated COVID-19 vaccines for kids under age 5 -EquityExchange
The FDA clears updated COVID-19 vaccines for kids under age 5
View
Date:2025-04-17 08:52:08
U.S. regulators on Thursday cleared doses of the updated COVID-19 vaccines for children younger than age 5.
The Food and Drug Administration's decision aims to better protect the littlest kids amid an uptick in COVID-19 cases around the country — at a time when children's hospitals already are packed with tots suffering from other respiratory illnesses including the flu.
"Vaccination is the best way we know to help prevent the serious outcomes of COVID-19, such as hospitalization and death," Dr. Peter Marks, FDA's vaccine chief, told The Associated Press.
Omicron-targeted booster shots made by Moderna and rival Pfizer already were open to everyone 5 and older.
The FDA now has authorized use of the tweaked shots starting at age 6 months — but just who is eligible depends on how many vaccinations they've already had, and which kind. Only about 5% of youngsters under age 5 have gotten the full primary series since vaccinations for the littlest kids began in June.
The FDA decided that:
--Children under age 6 who've already gotten two original doses of Moderna's COVID-19 vaccine can get a single booster of Moderna's updated formula if it's been at least two months since their last shot.
--Pfizer's vaccine requires three initial doses for tots under age 5 — and those who haven't finished that vaccination series will get the original formula for the first two shots and the omicron-targeted version for their third shot.
The Centers for Disease Control and Prevention is expected to sign off soon, the final step for shots to begin.
Marks said the bivalent vaccine is safe for tots and will help parents "keep the protection for those children as up to date as possible."
But children under 5 who already got all three Pfizer doses aren't yet eligible for an updated booster.
For now, "the good news is they are probably reasonably well-protected," Marks said.
The FDA expects data from Pfizer and its partner BioNTech sometime next month to determine whether those tots will need an omicron-targeted booster "and we will act on that as soon as we can," he said.
For parents who haven't yet gotten their children vaccinated, it's not too late — especially as "we are entering a phase when COVID-19 cases are increasing," Marks said.
The updated vaccines from Moderna and Pfizer are combination shots, containing half the original vaccine and half tweaked to match the BA.4 and BA.5 omicron strains that until recently were dominant. Now BA.5 descendants are responsible for most COVID-19 cases.
The CDC last month released the first real-world data showing that an updated booster, using either company's version, does offer added protection to adults. The analysis found the greatest benefit was in people who'd never had a prior booster, just two doses of the original COVID-19 vaccine — but that even those who'd had a summertime dose were more protected than if they'd skipped the newest shot.
veryGood! (973)
Related
- Which apps offer encrypted messaging? How to switch and what to know after feds’ warning
- North Carolina lawmakers appeal judge’s decision blocking abortion-pill restrictions
- Man accused of killing 7 at suburban Chicago July 4 parade might change not-guilty plea
- She asked 50 strangers to figure out how she should spend her $27 million inheritance. Here's what they came up with.
- Behind on your annual reading goal? Books under 200 pages to read before 2024 ends
- McDonald's set to roll out $5 value meal. Here's what that buys you.
- World's oldest deep sea shipwreck discovered off Israel's coast
- Dollar Tree left lead-tainted applesauce on shelves for weeks after recall, FDA says
- US appeals court rejects Nasdaq’s diversity rules for company boards
- Caeleb Dressel wins 50 free at Olympic Trials. At 27, he is America's fastest swimmer
Ranking
- Bill Belichick's salary at North Carolina: School releases football coach's contract details
- Gene therapy may cure rare diseases. But drugmakers have few incentives, leaving families desperate
- College World Series championship round breakdown: Does Tennessee or Texas A&M have the edge?
- Texas medical panel issues new guidelines for doctors but no specific exceptions for abortion ban
- Backstage at New York's Jingle Ball with Jimmy Fallon, 'Queer Eye' and Meghan Trainor
- AP Week in Pictures: Global
- South Carolina governor visiting Germany, a major driver of the state’s economy
- Capital murder charges filed against 2 Venezuelan men in the death of a 12-year-old girl in Houston
Recommendation
Former Danish minister for Greenland discusses Trump's push to acquire island
New state program aims to put 500,000 acres of Montana prairie under conservation leases
Federal judge to consider a partial end to special court oversight of child migrants
Amtrak resumes service after disruptions along Northeast corridor amid severe heat wave
'Squid Game' without subtitles? Duolingo, Netflix encourage fans to learn Korean
Gold bars and Sen. Bob Menendez’s curiosity about their price takes central role at bribery trial
Kate Middleton Celebrates Prince William's Birthday With New Family Photo
Prosecutors drop most charges against student protesters who occupied Columbia University building